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The C syndrome is characterized by trigonocephaly and associated anomalies, such as unusual facies, psychomotor
retardation, redundant skin, joint and limb abnormalities, and visceral anomalies. In an individual with the C syndrome
who harbors a balanced chromosomal translocation, t(3;18)(q13.13;q12.1), we discovered that the TACTILE gene for
CD96, a member of the immunoglobulin superfamily, was disrupted at the 3q13.3 breakpoint. In mutation analysis of
nine karyotypically normal patients given diagnoses of the C or C-like syndrome, we identified a missense mutation
(839CrT, T280M) in exon 6 of the CD96 gene in one patient with the C-like syndrome. The missense mutation was not
found among 420 unaffected Japanese individuals. Cells with mutated CD96 protein (T280M) lost adhesion and growth
activities in vitro. These findings indicate that CD96 mutations may cause a form of the C syndrome by interfering with
cell adhesion and growth.
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The C (Opitz trigonocephaly) syndrome (MIM %211750)
is a malformation syndrome of unknown cause, and its
mode of inheritance has been suggested to be autosomal
recessive. The syndrome comprises trigonocephaly and
associated anomalies, such as unusual facies, wide alveo-
lar ridges, multiple buccal frenula, limb defects, visceral
anomalies, redundant skin, psychomotor retardation, and
hypotonia.1,2
Recently, Bohring et al.3,4 suggested the delineation or
existence of a severe form of the C syndrome (the C-like
syndrome, or Bohring-Opitz syndrome [MIM 605039]).
More recently, Osaki et al.5 reported on a newborn infant
who had many clinical features similar to those of the C-
like syndrome but did not have exophthalmoses, which
has been regarded as a hallmark of the C-like syndrome.
They suggested that the manifestations in this patient
are a further indication of overlap between the C-like syn-
drome and the C syndrome. Thus, it is controversial
whether there is (1) a gradient of spectrum in the C syn-
drome, from the mild form (C syndrome) to the severe
form (C-like syndrome), or (2) genetic heterogeneity
among the patients with the C syndrome.
In addition, various chromosomal abnormalities, es-
pecially those that include chromosome 3, have been re-
ported in patients originally described as having the C
syndrome.2 These include 3p monosomy,6 distal 3p tri-
somy,7 3q trisomy,8 distal 3q trisomy with deletion of dis-
tal 3p,9 and inversion in chromosome 3.10 Although these
cases might be removed from the C syndrome because
they involve chromosome abnormalities, it is possible that
there could be putative genes (or multiple loci) related to
trigonocephaly and, even further, to pathogenesis of the
C syndrome in chromosome 3.2,10
We encountered a boy with the C syndrome and a de
novo balanced translocation,46,XY,t(3;18)(q13.13;q12.1).11
By construction of a BAC/cosmid contig covering the
breakpoints, we found the CD96 (TACTILE) gene (Gen-
Bank accession number NM_198196) encoding a mem-
ber of the immunoglobulin superfamily12 at the 3q13.13
breakpoint (fig. 1A). The CD96 gene consists of 15 exons
and spans ∼120 kb in the genome. Precise structural anal-
ysis around the breakpoint showed that the gene was dis-
rupted by the translocation in exon 5, probably leading
to premature termination or loss of expression of CD96
protein. There is no gene or poly-A signal in a 500-kb
region telomeric to the breakpoint of chromosome 18,
according to the Ensembl Genome Browser Web site. FISH
analysis with use of a BAC clone, RP11-158B11, demon-
Figure 1. CD96 mutations in the C or C-like syndrome and its expression. A, BAC and cosmid/plasmid map spanning the 3q13.3
breakpoint of a patient with a translocation, t(3;18)(q13.13;q12.1). The red vertical line and dashed red line indicate the breakpoint.
Blue bars for BACs or plasmids indicate clones covering the breakpoint (detected by FISH analysis). A red horizontal arrow indicates
the CD96 gene. A red vertical arrow indicates the breakpoint in the CD96 gene. B, FISH analysis of the patient harboring the translocation.
FISH signals for BAC RP11-159B11 are separated into two chromosomes, der(3) and der(18), whose signals are indicated by arrowheads.
An arrow indicates signals on a normal chromosome 3. C, RT-PCR for CD96 expression in the B cells of an unaffected individual and
the patient with C syndrome. The left, middle, and right lanes depict a 100-bp ladder, an unaffected control, and the patient with C
syndrome with translocation, respectively. The lower panel indicates expression of GAPDH as the control. D, Direct DNA-sequence analysis
of CD96 demonstrates a point mutation in a patient. E–H, Immunocytochemical analysis for CD96 localization in HT1080 cells with use
of rabbit anti-CD96 antibody and FITC-conjugated (E) or HRP-conjugated (G–H) goat anti-rabbit IgG. E, Counterstained with 4′,6-
diamidino-2-phenylindole (original magnification 400#). F–H, Counterstained with methyl green. F, Negative control. Original mag-
nification was 100# (F and G) or 400# (H). White arrows (E) and black arrows (H) indicate regions adherent to the plastic dish.
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Table 1. Comparison of Manifestations between Two of Our Patients and Frequencies of Major
Findings in the C or C-like Syndromes
Clinical Finding
Presence ina Frequency in
Patient with
Translocation
Patient with
Mutation
C
Syndrome2
C-like
Syndrome4
Trigonocephaly   23/23 13/13
Upslanting palpebral fissures   22/23 13/13
Epicanthal folds   20/22 NM
Prominent eyes   NM 13/13
Strabismus   16/22 8/8
Depressed nasal bridge   15/22 13/13
Anomalous and posteriorly angulated ears   18/21 12/13b
Wide alveolar ridges   10/18 4/6
High-arched palate   NM NM
Capillary hemangioma   9/17 13/13
Redundant skin   14/20 NM
Joint contractures   7/21 13/13
Agenesis of the corpus callosum   NM 7/10
Failure to thrive   NM 11/11
Intrauterine growth retardation   NM 12/13
Seizures   5/19 5/5
Developmental retardation   18/19 9/9
Congenital heart anomalies   11/22 5/11
Clinical diagnosis C syndrome C-like syndrome … …
NOTE.—NM p not mentioned.
a  p present;  p absent.  p borderline.
b Low-set ears.
Table 2. Sequencing Primers and PCR Conditions for the CD96 and ZBED2 Genes
Primer Name
Sequence
(5′r3′)
Tm
a
(C)
MgCl2
(mM)
Size
(bp)Forward Reverse
hCD96 ex1 CAACTGCTCTGCGTGATATC ACCCTTAGTAATGATTTGTCCT 60 2.5 540
hCD96 ex2 CCTAAAGCAGCCAGGGAGAAA ATGCTGAGCACCAAGCCTAAC 58 1.25 657
hCD96 ex3 GAGGACAGATGAATCCCTATAC ATAGACTCAGAGGCTTGCCTG 60 1.8 424
hCD96 ex4 CAGACTTGCCAGTGCTGAGT GGATGGACTAAGGTAGACTTC 60 1.8 380
hCD96 ex5 GTAAATGAATCAGTGCTTGTCGA GTATCCAGGGAAACAGACTCC 62 2.5 429
hCD96 ex6 TCTGTATTCCCATGAAACTGTAG TATGCAACCTGACACACCTTAC 60 1.8 367
hCD96 ex7 CATCTCTATAGGAGATAGCCCA ACACTCCACCCCCTTGGAAG 58 1.25 472
hCD96 ex8 TTGATCATGCCATGCCTTGGC TTTCACTGGAGTCCTACTTGTC 58 1.25 446
hCD96 ex9 GCTGCCTAGTTTCCAGGCCA ATGGGCAAGTTAATGTGACGTG 58 1.25 485
hCD96 ex10 GGCTGTTCACTAAGATTCTTTCC TAGTCACCGCAGAGTAACCCA 58 1.25 343
hCD96 ex11 GCCAGCTAGTGTTCCTGCATA GTCCATGGGTGTAGTCTCAGA 60 1.8 386
hCD96 ex12 CAAGAATCCCTTCAACTCCCAC TATATCTATCTGAGGCTGGCTTC 62 1.8 355
hCD96 ex13 CAAATCTCAGGATCCCAGCCT TTGACCCTGACAACACCTTATC 62 1.25 499
hCD96 ex14 GCTTAGACATGCCCACCTCC CAGCCTGACTAGGCCAATGC 62 1.25 488
hCD96 ex15 TGTGACTAACAGGCACAGGGT GGTTAAGCTTCAGGCGTTTGG 58 1.25 467
hCD96 ex15-2 GAGAGCCAGAACTACCCAGC CCACTCCCTACCCCCACTTT 62 1.8 372
hZBED2 15 TGTGGTTCAAATAAGCTTTTGGC … 60 1.25 934
hZBED2 23 GTTTCGGCCAAGGGTCAGCA … … … …
hZBED2 35 ACATGATGAGGCGGGAAGACGA … 60 1.25 657
hZBED2 43 AACAAAATGGAAGGGATGTACTG … … … …
a Annealing temperature.
strated split signals on the two derivative chromosomes 3
and 18 (fig. 1B). Semiquantitative RT-PCR analysis showed
that CD96 expression in B cells of the patient was reduced
to 45.8% of the normal level (fig. 1C). Although one of
the zinc-finger genes, ZEBD2 (GenBank accession number
NM_024508.3) exists near the breakpoint, in intron 6 of
CD96 it has the opposite direction (fig. 1A), and its ex-
pression was not reduced in the patient (data not shown).
At the other breakpoint, 18q12.1, we could not find any
genes or ESTs, according to the Genome Browser Web site
(data not shown). We surveyed in this patient copy-num-
ber changes for the whole genome by the use of Human
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Figure 2. Expression of the CD96 gene in fetal and adult tissues. A, Expression in human tissues. An arrow indicates CD96 cDNA. An
arrowhead indicates GAPDH cDNA as control. Lane M, size marker (100-bp ladder); 1, brain (whole); 2, cerebellum; 3, spinal cord; 4,
heart; 5, kidney; 6, lung; 7, skeletal muscle; 8, spleen; 9, thymus; 10, trachea; 11, stomach; 12, small intestine; 13, colon; 14, salivary
gland; 15, prostate; 16, testis; 17, uterus; 18, placenta; 19, fetal brain; 20, fetal liver; and 21, bone. Lanes 1–17 and 21, adult tissues.
Lanes 19 and 20, fetal tissues. B–F, Whole mount in situ hybridization with Cd96 antisense RNA in 10-dpc mouse embryo, showing
high expression in developing forehead (arrow in B) and in heart and blood vessels (arrowheads in B). D–F, Horizontal sections of the
embryo. Cd96 is expressed in the pharynx (arrow in D); in cardiac jelly, endocardial cells, and blood cells (arrow in E); and in forebrain
tissues (arrow in F). All sections are counterstained with nuclear fast red.
Mapping 50K Array Xba240 (Affymetrix). No pathogenic
deletions or duplications were detected (data not shown).
We examined nine karyotypically normal Japanese pa-
tients who were given clinical diagnoses of the C or C-
like syndrome. The syndromes were diagnosed by the
presence of trigonocephaly and associated combinations
of major clinical findings that are observed in 170% of
reported patients with the C or C-like syndromes—that
is, upslanting palpebral fissures, epicanthial folds, strabis-
mus, depressed nasal root, anomalous and posteriorly an-
gulated ears, capillary hemangioma, redundant skin, and
joint contractures (table 1).2 Two of the patients were re-
ported as having C-like syndrome,5,13 and the information
about seven others was unpublished. First, we examined
these patients for deletions or duplications by FISH anal-
ysis, using RP11-159B11 as a probe. However, no deletions
were detected in any of them (data not shown). We then
performed direct sequencing analysis of the candidate
genes, CD96 and ZEBD2. Primer pairs and PCR conditions
for amplification of the candidate genes are listed in table
2. In one patient who was given a diagnosis of C-like
syndrome,5 we identified a de novo missense mutation
(c.839CrT) in exon 6 of CD96 (fig. 1D). The c.839CrT
substitution predicts a threonine-to-methionine change
(T280M) at nucleotide position 839, close to the third im-
munoglobulin-like domain. The threonine residue was
conserved in some species—that is, chimpanzee, monkey,
dog, opossum, and armadillo. The missense mutation was
not found among 420 unaffected Japanese individuals.
Two patients had a homozygous 5-bp insertion (c.856-
80insTTATG) in intron 6 of the CD96 gene. They showed
an ∼40% reduction of CD96 expression in their B cells,
compared with the normal control level (data not shown).
However, this homozygous 5-bp insertion was found in 2
of 196 normal Japanese individuals examined. No copy-
number variation around this region has been registered
in the Database of Genomic Variants. Therefore, it is am-
biguous whether the insertion is directly associated with
the syndrome. There is also a possibility that small mu-
tations in the promoter or enhancer region of CD96 or
other mutations that affect CD96 expression, albeit un-
detected by our analyses, might reduce the gene expres-
sion in the patients. No mutation in ZEBD2 was found in
any of the nine Japanese patients (data not shown).
We also examined 20 white patients for the CD96 gene,
18 of whom were given clinical diagnoses of the C syn-
drome and 2 of whom were given diagnoses of the C-like
syndrome. However, the direct sequencing analysis could
not detect any apparent mutations in any exons of the
CD96 gene in these patients.
The patient having the missense mutation in CD96 had
the following relatively severe clinical manifestations: tri-
gonocephaly, ridging of the metopic suture with narrow
forehead, a small hemangioma near the nose, thin upper
www.ajhg.org The American Journal of Human Genetics Volume 81 October 2007 839
Figure 3. Functional characterization of wild-type and mutated
CD96 proteins. A and B, Cell-adhesion assay for tissue-culture
plates. A, Images captured after exposure with vibration for 20
min and 70 min. HT1080 indicates untransfected cells (control);
wCD96 indicates highly expressed clone for wild-type CD96 in
HT1080; and mCD96 indicates highly expressed clone for mutated
CD96 in HT1080. The arrow indicates attached cell. Arrowheads
indicate nonattached cells. B, Quantitated adhesion activity in
each transformant. Attached cells and nonattached cells are
counted in more than five different fields under a microscope. A
total of at least 500 cells were counted for each experiment. Error
bars are meanSD. Adhesion activities are indicated by percent-
ages of attached cells per total cell number at 0 min, 20 min, 70
min, and 150 min after spreading cells. C, Cell proliferation as-
sessed by a tetrazolium-based (MTS) assay. The ordinates show
the cell number expressed as arbitrary units. Two wCD96s are clones
highly expressing wild-type CD96, HT1080 is an untransfected con-
trol clone, and mCD96 is a clone expressing mutated CD96. Error
bars are meanSD. Data shown are from three independent ex-
periments, each performed in quadruplicate ( ).np 12
lip, long philtrum, a high-arched palate with deep groove,
low-set ears, a short neck, cryptorchidism, abnormality of
the ventricular myocardium, mild optic-nerve atrophy,
and hypoplasia of the corpus callosum, all of which led
to the diagnosis of the C-like syndrome (table 1).5 The
patient harboring the balanced translocation had less se-
vere manifestations—that is, trigonocephaly, a prominent
metopic ridge, upslanting palpebral fissures, epicanthal
folds, thick and irregular alveolar ridges, thin upper lip,
long philtrum, low-set ears, redundant nuchal skin, and
agenesis of the corpus callosum (table 1).11 His phenotype
satisfied the diagnosis of the C syndrome.
CD96 was identified as a human T-cell–activatedantigen
in long-term culture and is known to interact with the
poliovirus receptor, CD155, to recognize targets for natural
killer (NK) cells.14 To determine a possible role of CD96 in
the C syndrome, we investigated its expression and func-
tion in humans and mice. CD96 was found to be localized
in the cytoplasm and cell-adhesion sites of the cell surface
when it was expressed in HT1080 cells (fig. 1E–1H). A
CD96-CFP fusion protein gave the same result when it
was transiently expressed in HT1080 (data not shown).
These findings support the hypothesis that CD96 may act
as a cell-adhesion molecule, as do some other proteins of
the immunoglobulin superfamily, such as nectin.15 The
human CD96 gene is strongly expressed in the adult lung,
spleen, and thymus and is moderately expressed in the
adult spinal cord, kidney, trachea, digestive tissues, pros-
tate, placenta, bone, and fetal brain and liver (fig. 2A). In
10-d-postcoitum mouse (dpc) embryos, Cd96 is expressed
in the forebrain and in a front part of the head tissues,
cardiac jelly, endothelial cells, pharynx, and blood cells
(fig. 2B–2F). These expression patterns are consistent with
organs and tissues involved in the abnormalities of the C
syndrome—that is, trigonocephaly, redundant nuchal skin,
and cardiovascular abnormalities.
To analyze a potential role of CD96 in the morpholog-
ical abnormalities of the C syndrome, we investigated the
function of wild-type CD96 (wCD96) and mutated CD96
(mCD96 [c.839CrT]) in vitro. We constructed expression
vectors for wCD96 and mCD96 using the strong CAG pro-
moter,16 introduced each vector into HT1080 cells, and
compared the characteristics of each transformant. A cell-
adhesion assay with the HT1080 cell clones expressing
wCD96 showed faster attachments on tissue-culture plates
compared with mock clones, even under the condition of
10% serum-containing medium (fig. 3A and 3B), whereas
those expressing mCD96 showed the same adherent ac-
tivity as the mock cells (fig. 3A and 3B). The result suggests
that CD96 protein is involved in cell-matrix adhesion in
transfected HT1080 cells, but mCD96 protein loses the
activity. A tetrazolium-based (MTS) assay on the transfor-
mants, performed to determine their effect on cell growth,
showed 1.5 times more growth-promoting activity of
wCD96 than was shown of mCD96 in HT1080 (fig. 3C).
Many cell-adhesion molecules belonging to the immu-
noglobulin super family (IgCAMs) play important roles
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during embryogenesis or morphogenesis.17 For example,
mutations in the gene for PVRL1/nectin-1, a member of
IgCAM, are involved in the cause of cleft lip/palate–ec-
todermal dysplasia syndrome (MIM #225000).18,19
The original report and other reports of affected sibs
with the C syndrome suggested that the syndrome is in-
herited in an autosomal recessive fashion.1,2 Normal chro-
mosomes in most patients, unaffected parents with mul-
tiaffected offsprings, the equal sex ratio of affected indi-
viduals, and consanguineous matings1,2,8 all support auto-
somal recessive inheritance. Meanwhile, many other pa-
tients have sporadic disease,2 and recurrence risk may be
estimated to be 10%,8 which suggests the possibility of
dominant inheritance or germline mosaicism.2,8,10 These
findings imply that the C syndrome is genetically hetero-
geneous, and its inheritance mode is in debate. The CD96
aberrations found in our two patients were both in the
heterozygous state without a copy-number variation in
this region, which is consistent with an autosomal dom-
inant condition. Since it is hard to assume that all reported
sib cases would have originated in germline mosaicism in
their respective parents, the CD96 deficiency identified in
our patients cannot explain all patients with the C syn-
drome. However, since genetic heterogeneity is evident in
the syndrome and many sporadic cases are known, our
results suggest that a form of the C syndrome is caused
by dysfunction of CD96. At least, the fact the mutations
were found in the C and C-like syndromes may indicate
that they are allelic.
A similar example is Cohen syndrome, where only
∼20% of patients were found to have mutations in a caus-
ative gene, COH1.20,21 The identification of a causative
gene, CD96, may open a door to an understanding of the
molecular pathology of the C syndrome.
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